Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity.

Hdl Handle:
http://hdl.handle.net/10147/237914
Title:
Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity.
Authors:
Manecksha, Rustom P; Cullen, Ivor M; Ahmad, Sarfraz; McNeill, Graeme; Flynn, Robert; McDermott, Thomas E D; Grainger, Ronald; Thornhill, John A
Affiliation:
Department of Urology, Adelaide & Meath Hospital, Dublin, Ireland. rustom.manecksha@gmail.com
Citation:
Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity. 2012, 61 (5):928-35 Eur. Urol.
Journal:
European urology
Issue Date:
May-2012
URI:
http://hdl.handle.net/10147/237914
DOI:
10.1016/j.eururo.2011.10.043
PubMed ID:
22078337
Abstract:
Botulinum toxin A is effective for treatment of idiopathic detrusor overactivity (IDO). The trigone is generally spared because of the theoretical risk of vesicoureteric reflux (VUR), although studies assessing injection sites are lacking.
Item Type:
Article
Language:
en
MeSH:
Adolescent; Adult; Aged; Botulinum Toxins, Type A; Female; Humans; Male; Middle Aged; Questionnaires; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Young Adult
ISSN:
1873-7560

Full metadata record

DC FieldValue Language
dc.contributor.authorManecksha, Rustom Pen_GB
dc.contributor.authorCullen, Ivor Men_GB
dc.contributor.authorAhmad, Sarfrazen_GB
dc.contributor.authorMcNeill, Graemeen_GB
dc.contributor.authorFlynn, Roberten_GB
dc.contributor.authorMcDermott, Thomas E Den_GB
dc.contributor.authorGrainger, Ronalden_GB
dc.contributor.authorThornhill, John Aen_GB
dc.date.accessioned2012-08-09T10:59:58Z-
dc.date.available2012-08-09T10:59:58Z-
dc.date.issued2012-05-
dc.identifier.citationProspective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity. 2012, 61 (5):928-35 Eur. Urol.en_GB
dc.identifier.issn1873-7560-
dc.identifier.pmid22078337-
dc.identifier.doi10.1016/j.eururo.2011.10.043-
dc.identifier.urihttp://hdl.handle.net/10147/237914-
dc.description.abstractBotulinum toxin A is effective for treatment of idiopathic detrusor overactivity (IDO). The trigone is generally spared because of the theoretical risk of vesicoureteric reflux (VUR), although studies assessing injection sites are lacking.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to European urologyen_GB
dc.subject.meshAdolescent-
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshBotulinum Toxins, Type A-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshQuestionnaires-
dc.subject.meshTreatment Outcome-
dc.subject.meshUrinary Bladder-
dc.subject.meshUrinary Bladder, Overactive-
dc.subject.meshYoung Adult-
dc.titleProspective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Urology, Adelaide & Meath Hospital, Dublin, Ireland. rustom.manecksha@gmail.comen_GB
dc.identifier.journalEuropean urologyen_GB
dc.description.provinceLeinsteren
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.